Furthermore, as a secreted protein, increased expression of SMOC2 may shed off into the urine at earlier stages of RCC and reveal its translational potential as a non-invasive biomarker, as we have shown in fibrotic kidneys [22]. This evidence concerns the gene SMOC2 and renal cell carcinoma.